Infectious Diseases Market Research Report, Growth & Forecast

The Catheter-Related Bloodstream Infection (CRBSI) Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and st...

Global Human Immunodeficiency Virus Type-1 (HIV-1) Treatment Market reached US$ 39,670.14 million in 2023 and is expected to reach US$ 62,752.56 million by 2031, growing with a CAGR of 5.90% during th...

Herpes Labialis Drugs Market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Herpes Labialis D...

Invasive Fungal Infection Treatment Market reached US$ 10.6 billion in 2023 and is expected to reach US$ 14.6 billion by 2031, growing with a CAGR of 4.10% during the forecast period 2026-2031. The In...

Chlamydia Infection Treatment Market reached US$ 1.71 billion in 2023 and is expected to reach US$ 2.46 billion by 2031, growing with a CAGR of 4.70% during the forecast period 2026-2031. The Chlamydi...

... manufacturers of Acinetobacter Infections Treatment, with price, sales, revenue and global market share of Acinetobacter Infections Treatment in 2017 and 2018. Chapter 3, the Acinetobacter Infections Treatment competitive situation, sales, revenue and global market share ...

... the global Hospital-Acquired Pneumonia Prevention market. Chapter 1, to describe Hospital-Acquired Pneumonia Prevention Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Hospital-Acquired Pneumonia Prevention ...

According to our (Global Info Research) latest study, the global Drugs for Malaria market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR...

According to our (Global Info Research) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2904 million in 2025 and is forecast to a readjusted size of US$...

This study covers the world outlook for anti-jamming across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...

This study covers the world outlook for chlamydia infection diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

This study covers the world outlook for clostridium Difficile infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indus...

This study covers the world outlook for clostridium Difficile treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnin...

This study covers the world outlook for communicable diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...

This study covers the world outlook for community acquired pneumonia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...

This study covers the world outlook for cryptococcosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...

This study covers the world outlook for enteric disease testing-treatment across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni...

This study covers the world outlook for gram-positive bacterial infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earn...

This study covers the world outlook for healthcare acquired infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

This study covers the world outlook for herpes simplex virus infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

This study covers the world outlook for hospital-acquired pneumonia prevention across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

The global Acinetobacter Infections Treatment market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Acinetobacter is a group of...

The global Drugs for Herpes Labialis (Oral Herpes) market size is expected to reach $ 4013 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032). Herpes Labial...

The global Drugs for Malaria market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Drugs for malaria or antimalarial medication...

The global Hospital-Acquired Pneumonia Prevention market size is expected to reach $ 298 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032). Dental plaque i...

The Dengue – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers i...

Monkeypox Market reached US$ 93.17 million in 2023 and is expected to reach US$ 264 million by 2031, growing with a CAGR of 10.16% during the forecast period 2026-2031. The Monkeypox Market emerges as...

The Global Chikungunya Fever Market, valued at USD 493.23 Million in 2024, is projected to experience a CAGR of 7.28% to reach USD 751.91 Million by 2030. The Global Chikungunya Fever Market encompass...

The Global Perinatal Infections Market, valued at USD 1.60 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 2.18 Billion by 2030. The Global Perinatal Infections Market focuses...

According to our latest research, the global AI-based Malaria Solution market size will reach USD 686 million in 2031, growing at a CAGR of 7.9% over the analysis period. AI-based Malaria Solution ref...

Global HIV Therapeutics Market reached US$ 37.61 Billion in 2024 and is expected to reach US$ 57.56 Billion by 2033, growing with a CAGR of 4.80% during the forecast period 2026-2033. The Global HIV T...

Global Respiratory Syncytial Virus (RSV) Market reached US$ 1.95 billion in 2024 and is expected to reach US$ 4.54 billion by 2033, growing with a CAGR of 9.90% during the forecast period 2026-2033. T...

According to Stratistics MRC, the Global Infectious Disease Management Market is accounted for $23.3 billion in 2025 and is expected to reach $38.9 billion by 2032 growing at a CAGR of 7.6% during the...

The Sexually Transmitted Infections (Stis) Market is valued at USD 61.4 billion in 2025 and is projected to grow at a CAGR of 13.7% to reach USD 194.5 billion by 2034.The global sexually transmitted i...

The global Cerebral Malaria Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the lat...

According to this study, the global Ebola Treatment market size will reach US$ million by 2031. Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called...

The global C Difficile Infection Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...

The global Klebsiella Pneumoniae Infection Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of...

The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The...

The global Candidiasis Therapeutics market size is predicted to grow from US$ 3222 million in 2025 to US$ 3920 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact o...

The global Chagas Disease Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...

According to this study, the global Hepatitis C Drugs market size will reach US$ million by 2031. Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-l...

The global necrotizing fasciitis market size was estimated at USD 1,027.24 million in 2024 and is projected to reach USD 2,097.81 million by 2033, growing at a CAGR of 8.3% from 2025 to 2033. The mark...

Infectious Diseases Treatment Market Size & Industry Outlook The global infectious diseases treatment market size reached US$ 189.09 Billion in 2024 from US$ 182.65 Billion in 2023 and is expected to...

Valley Fever Market Size & Industry Outlook The global valley fever market size reached US$ 1.03 Billion with rise of US$ 1.10 Billion in 2024 is expected to reach US$ 1.98 Billion by 2033, growing at...

The Influenza A – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report deliv...

The Tuberculosis – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report deli...

Valley Fever Market reached US$ 1.10 Billion in 2024 and is expected to reach US$ 1.98 Billion by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Valley Fever Market emerg...

Neglected Tropical Disease Treatment Market The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, gr...

Global Avian Influenza Treatment Market reached US$ 11.38 billion in 2023 and is expected to reach US$ 28.22 billion by 2033, growing with a CAGR of 9.60% during the forecast period 2026-2033. The Glo...